<code id='2233741012'></code><style id='2233741012'></style>
    • <acronym id='2233741012'></acronym>
      <center id='2233741012'><center id='2233741012'><tfoot id='2233741012'></tfoot></center><abbr id='2233741012'><dir id='2233741012'><tfoot id='2233741012'></tfoot><noframes id='2233741012'>

    • <optgroup id='2233741012'><strike id='2233741012'><sup id='2233741012'></sup></strike><code id='2233741012'></code></optgroup>
        1. <b id='2233741012'><label id='2233741012'><select id='2233741012'><dt id='2233741012'><span id='2233741012'></span></dt></select></label></b><u id='2233741012'></u>
          <i id='2233741012'><strike id='2233741012'><tt id='2233741012'><pre id='2233741012'></pre></tt></strike></i>

          knowledge

          knowledge

          author:explore    Page View:9657

          Has AI really solved biology? What can machines teach us about medicine? And what’s a digital twin?

          We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. It’s our all-AI episode. First, STAT’s Casey Ross joins us to explain his reporting on how researchers and pharmaceutical firms are using the technology to find new drug targets, design therapies, and improve clinical trials. Then, we talk to Joel Dudley, a partner at the venture firm Innovation Endeavors, about how to discern promising ideas from wastes of time when it comes to AI in biotech.

          advertisement

          For more on what we cover, here’s the latest on AI in drug development; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

          Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

          And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

          advertisement

          comprehensive

          Medicare proposal to cover medical devices draws a mixed reaction
          Medicare proposal to cover medical devices draws a mixed reaction

          AdobeThemedicaldeviceindustryissplitonwhetheraproposednewMedicarereimbursementpathwaywilldoanythingt

          read more
          Will biotech layoffs continue through 2023?
          Will biotech layoffs continue through 2023?

          KaraColuccio,amanagingpartneratPerspectiveGroup,saysthejobmarketforbiotechexecutiveshasgottenmuchtig

          read more
          Sports medicine is finally prioritizing gender equality
          Sports medicine is finally prioritizing gender equality

          MollyFergusonforSTATWhencyclistAlisonTetrickjoinedthesport’sprofessionalranks,shereceivedtheperkstha

          read more

          HIV vaccine remains elusive. Immunologists keep trying new ideas

          SethPincus,ElizabethFischerandAustinAthman,NationalInstituteofAllergyandInfectiousDiseases/NIHHIVhas